Throughput Optimization in High Speed Downlink Packet Access (HSDPA)

In this paper, we investigate throughput optimization in High Speed Downlink Packet Access (HSDPA). Specifically, we propose offline and online algorithms for adjusting the Channel Quality Indicator (CQI) used by the network to schedule data transmission. In the offline algorithm, a given target BLER is achieved by adjusting CQI based on ACK/NAK history. By sweeping through different target BLERs, we can find the throughput optimal BLER offline. This algorithm could be used not only to optimize throughput but also to enable fair resource allocation among mobile users in HSDPA. In the online algorithm, the CQI offset is adapted using an estimated short term throughput gradient without specifying a target BLER. An adaptive stepsize mechanism is proposed to track temporal variation of the environment. We investigate convergence behavior of both algorithms. Simulation results show that the proposed offline algorithm can achieve the given target BLER with good accuracy. Both algorithms yield up to 30% HSDPA throughput improvement over that with 10% target BLER

A novel sponge-submerged membrane bioreactor (SSMBR) for wastewater treatment and reuse

Membrane fouling has been regarded as one of the biggest challenges to widespread application of membrane bioreactor (MBR). This study focuses on minimizing the membrane fouling and improving the performance of submerged membrane bioreactor (SMBR) by porous sponge addition. The effects of sponge addition on sustainable flux and membrane fouling were investigated. Acclimatized sponge could significantly increase the suspended growth in SMBR with biomass of 16.7g/L(sponge). With the sponge volume fraction of 10%, SSMBR could enhance sustainable flux up to 50L/m2h compared with sustainable flux of SMBR (only 25L/m2h). SSMBR also exhibited excellent results in terms of DOC removal (over 95%), COD removal (over 97%), lower transmembrane pressure development, and oxygen uptake rate. Over 89% of NH4-N and 98% of PO4-P were removed when SSMBR was operated with a MLSS concentration of 15g/L

Self-organization of developing embryo using scale-invariant approach

<p>Abstract</p> <p>Background</p> <p>Self-organization is a fundamental feature of living organisms at all hierarchical levels from molecule to organ. It has also been documented in developing embryos.</p> <p>Methods</p> <p>In this study, a scale-invariant power law (SIPL) method has been used to study self-organization in developing embryos. The SIPL coefficient was calculated using a centro-axial skew symmetrical matrix (CSSM) generated by entering the components of the Cartesian coordinates; for each component, one CSSM was generated. A basic square matrix (BSM) was constructed and the determinant was calculated in order to estimate the SIPL coefficient. This was applied to developing <it>C. elegans </it>during early stages of embryogenesis. The power law property of the method was evaluated using the straight line and Koch curve and the results were consistent with fractal dimensions (fd). Diffusion-limited aggregation (DLA) was used to validate the SIPL method.</p> <p>Results and conclusion</p> <p>The fractal dimensions of both the straight line and Koch curve showed consistency with the SIPL coefficients, which indicated the power law behavior of the SIPL method. The results showed that the ABp sublineage had a higher SIPL coefficient than EMS, indicating that ABp is more organized than EMS. The fd determined using DLA was higher in ABp than in EMS and its value was consistent with type 1 cluster formation, while that in EMS was consistent with type 2.</p

Comparison of the performance of submerged membrane bioreactor (SMBR) and submerged membrane adsorption bioreactor (SMABR)

This study focuses on comparing the performance of submerged membrane bioreactor (SMBR) and submerged membrane adsorption bioreactor (SMABR) over a period of 20 days at a hydraulic retention time (HRT) of 3.1 h. The effects of PAC on critical flux and membrane fouling were also investigated. The SMABR exhibited better results in terms of mixed liquor suspended solids (MLSS) growth, DOC removal (over 96%), COD removal (over 95%), transmembrane pressure (TMP) and oxygen uptake rate. Nearly 100% of bacteria and 100% of total coliforms were removed in both systems. The addition of PAC could maintain the critical flux at a lower TMP value (7.5 kPa), while irreversible fouling caused by PAC occurred when the filtration flux exceeded critical flux. © 2007 Elsevier Ltd. All rights reserved

Quantum models for dechanneling by point defects and extended defects

Consiglio Nazionale delle Ricerche - Biblioteca Centrale - P.le Aldo Moro, 7 , Rome / CNR - Consiglio Nazionale delle RichercheSIGLEITItal

Detrimental effects of a novel flow regime on the functional trajectory of an aquatic invertebrate metacommunity.

Novel flow regimes resulting from dam operations and overallocation of freshwater resources are an emerging consequence of global change. Yet, anticipating how freshwater biodiversity will respond to surging flow regime alteration requires overcoming two challenges in environmental flow science: shifting from local to riverscape-level understanding of biodiversity dynamics, and from static to time-varying characterizations of the flow regime. Here, we used time-series methods (wavelets and multivariate autoregressive models) to quantify flow-regime alteration and to link time-varying flow regimes to the dynamics of multiple local communities potentially connected by dispersal (i.e., a metacommunity). We studied the Chattahoochee River below Buford dam (Georgia, U.S.A.), and asked how flow regime alteration by a large hydropower dam may control the long-term functional trajectory of the downstream invertebrate metacommunity. We found that seasonal variation in hydropeaking synchronized temporal fluctuations in trait abundance among the flow-altered sites. Three biological trait states describing adaptation to fast flows benefitted from flow management for hydropower, but did not compensate for declines in 16 "loser" traits. Accordingly, metacommunity-wide functional diversity responded negatively to hydropeaking intensity, and stochastic simulations showed that the risk of functional diversity collapse within the next 4 years would decrease by 17% if hydropeaking was ameliorated, or by 9% if it was applied every other season. Finally, an analysis of 97 reference and 23 dam-affected river sites across the U.S. Southeast suggested that flow variation at extraneous, human-relevant scales (12-hr, 24-hr, 1-week) is relatively common in rivers affected by hydropower dams. This study advances the notion that novel flow regimes are widespread, and simplify the functional structure of riverine communities by filtering out taxa with nonadaptive traits and by spatially synchronizing their dynamics. This is relevant in the light of ongoing and future hydrologic alteration due to climate non-stationarity and the new wave of dams planned globally

A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2- advanced breast cancer (BELLE-4)

© The Author 2016.Background: Phosphatidylinositol 3-kinase (PI3K) pathway activation in preclinical models of breast cancer is associated with tumor growth and resistance to anticancer therapies, including paclitaxel. Effects of the pan-Class I PI3K inhibitor buparlisib (BKM120) appear synergistic with paclitaxel in preclinical and clinical models. Patients and methods: BELLE-4 was a 1:1 randomized, double-blind, placebo-controlled, adaptive phase II/III study investigating the combination of buparlisib or placebo with paclitaxel in women with human epidermal growth factor receptor 2- negative locally advanced or metastatic breast cancer with no prior chemotherapy for advanced disease. Patients were stratified by PI3K pathway activation and hormone receptor status. The primary endpoint was progression-free survival (PFS) in the full and PI3K pathway-activated populations. An adaptive interim analysis was planned following the phase II part of the study, after = 125 PFS events had occurred in the full population, to decide whether the study would enter phase III (in the full or PI3K pathway-activated population) or be stopped for futility. Results: As of August 2014, 416 patients were randomized to receive buparlisib (207) or placebo (209) with paclitaxel. At adaptive interim analysis, there was no improvement in PFS with buparlisib versus placebo in the full (median PFS 8.0 versus 9.2 months, hazard ratio [HR] 1.18), or PI3K pathway-activated population (median PFS 9.1 versus 9.2 months, HR 1.17). The study met protocol-specified criteria for futility in both populations, and phase III was not initiated. Median duration of study treatment exposure was 3.5 months in the buparlisib arm versus 4.6 months in the placebo arm. The most frequent adverse events with buparlisib plus paclitaxel (= 40% of patients) were diarrhea, alopecia, rash, nausea, and hyperglycemia. Conclusions: Addition of buparlisib to paclitaxel did not improve PFS in the full or PI3K pathway-activated study population. Consequently, the trial was stopped for futility at the end of phase II